When comparing Lantus (Insulin glargine) to other long-acting insulins, here are some key points based on the knowledge base:

Lantus (Insulin glargine)
- Type: Long-acting insulin
- Administration: Subcutaneous injection, once daily at the same time each day
- Forms: Liquid in vials or prefilled pens
- Common Side read more

When comparing Lantus (Insulin glargine) to other long-acting insulins, here are some key points based on the knowledge base:

Lantus (Insulin glargine)
- Type: Long-acting insulin
- Administration: Subcutaneous injection, once daily at the same time each day
- Forms: Liquid in vials or prefilled pens
- Common Side Effects: Hypoglycemia, hypokalemia, weight gain, minor redness or irritation at injection sites
- Rare but Serious Side Effects: Systemic allergic reaction

Other Long-Acting Insulins
- Degludec (Tresiba)
- Type: Long-acting insulin
- Duration: Effective for about 36 hours or longer
- Detemir (Levemir)
- Type: Long-acting insulin
- Duration: Effective for up to 24 hours
- Glargine U-300 (Toujeo)
- Type: Ultra long-acting insulin
- Administration: Subcutaneous injection, once daily at the same time each day
- Forms: Prefilled pen
- Common Side Effects: Hypoglycemia, hypokalemia, weight gain, rash, minor redness or irritation at injection sites

Summary
- Lantus and Toujeo are both forms of insulin glargine but differ in concentration and duration.
- Tresiba offers a longer duration of action compared to Lantus.
- Levemir has a similar duration to Lantus but may require different dosing schedules.

Each insulin type has its own specific characteristics and side effects, and the choice of insulin should be tailored to individual needs and medical advice.

 This AI-generated response comes from DiabetesTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Lantus (Insulin) for Diabetes | DiabetesTeam

Treatments for Type 2 Diabetes | DiabetesTeam